ISP-15-3 Analysis of Molecular Alteration in Endometrial Endometrioid Adenoarcinomas Using the Crypt Isolation Technique(Group 15 Oncology 6,IS Poster,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 2013-02-01
著者
-
Sugiyama Toru
Iwate Medical University
-
Kagabu Masahiro
Iwate Medical University
-
Takeuchi Satoshi
Iwate Medical University
-
Tomabechi Hidetoshi
Iwate Medical University
-
Suga Yasuko
Iwate Medical University
-
Nagasawa Takayuki
Iwate Medical University
関連論文
- K3-IS-2 Discovery of new biomarkers for screening of endometrial cancer of the uterus
- P1-IS-35 Clear cell carcinoma of the ovary : retrospective analysis of Japan Clear Cell Carcinoma Study
- Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin : retrospective analysis
- IS-15 Patients with stage IIIc ovarian clear cell carcinoma upstaged by lymph node metastasis have similar survival to other stage III clear cell carcinoma patients(Group2 Oncology2,International Session)
- Evidence-based guidelines for treatment of uterine body neoplasm in Japan : Japan Society of Gynecologic Oncology (JSGO) 2009 edition
- Identifying Prognostic Factors in Japanese Women with Pseudomyxoma Peritonei : A Retrospective Clinico-Pathological Study of the Tohoku Gynecologic Cancer Unit
- Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?
- ISO-1-5 New oncolytic HSV therapy for gynecologic cancer(Group 1 Oncology 1,IS Award Candidate,International Session)
- ISP-15-3 Analysis of Molecular Alteration in Endometrial Endometrioid Adenoarcinomas Using the Crypt Isolation Technique(Group 15 Oncology 6,IS Poster,International Session)
- ISP-3-3 Risk stratification for early detection of perinatal woman's myocardial impairment(Group 3 Perinatology 3,IS Poster,International Session)
- ISP-3-5 Feasibility of S-1/oxaliplatin (SOX) therapy in recurrent adenocarcinoma of the uterine cervix(Group 3 Oncology 3,IS Poster,International Session)